Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5428]
News [12616]
Articles [173]
Editorials [5]
Conferences [246]
elearning [17]
Tivantinib as second line therapy for high-MET HCC
Prof Lorenza Rimassa - Humanitas Cancer Center, Milan, Italy
Tivantinib as second line therapy for high-MET HCC ( Prof Lorenza Rimassa - Humanitas Cancer Center, Milan, Italy )
4 Jun 2017
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy
Prof Valentina Guarneri - Università degli Studi di Padova, Padua, Italy
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy ( Prof Valentina Guarneri - Università degli Studi di Padova, Padua, Italy )
4 Jun 2017
Expert prostate discussion: Clinical diagnostics, genomics, systemic and...
Dr Chris Parker and Prof Charles Ryan
Expert prostate discussion: Clinical diagnostics, genomics, systemic and radiological treatment ( Dr Chris Parker and Prof Charles Ryan )
4 Jun 2017
Web-based system for self-reporting symptoms may help patients live longer
Prof Ethan Basch - Lineberger Comprehensive Cancer Centre of the University of...
Web-based system for self-reporting symptoms may help patients live longer ( Prof Ethan Basch - Lineberger Comprehensive Cancer Centre of the University of North Carolina, USA )
4 Jun 2017
Olaparib slows growth of BRCA-related metastatic breast cancer
Dr Mark Robson - Memorial Sloan Kettering Cancer Center, New York, USA
Olaparib slows growth of BRCA-related metastatic breast cancer ( Dr Mark Robson - Memorial Sloan Kettering Cancer Center, New York, USA )
4 Jun 2017
Global study sets new risk-based standard to personalise chemotherapy for colon...
Dr Axel Grothey - Mayo Clinic Cancer Centre, Rochester, USA
Global study sets new risk-based standard to personalise chemotherapy for colon cancer after surgery ( Dr Axel Grothey - Mayo Clinic Cancer Centre, Rochester, USA )
4 Jun 2017
3 or 6 months adjuvant oxaliplatin for colorectal cancer
Dr Tim Iveson - University Hospital Southampton, Salisbury, UK
3 or 6 months adjuvant oxaliplatin for colorectal cancer ( Dr Tim Iveson - University Hospital Southampton, Salisbury, UK )
4 Jun 2017
Pooled analysis of avelumab for metastatic urothelial carcinoma
Dr Andrea Apolo - National Cancer Institute, Bethesda, USA
Pooled analysis of avelumab for metastatic urothelial carcinoma ( Dr Andrea Apolo - National Cancer Institute, Bethesda, USA )
3 Jun 2017
Cancer and living meaningfully: the CALM intervention
Dr Gary Rodin - Princess Margaret Cancer Centre, Toronto, Canada
Cancer and living meaningfully: the CALM intervention ( Dr Gary Rodin - Princess Margaret Cancer Centre, Toronto, Canada )
3 Jun 2017
Larotrectinib shows durable efficacy across diverse paediatric and adult cancers
Dr David Hyman - Memorial Sloan Kettering Cancer Centre, New York, USA
Larotrectinib shows durable efficacy across diverse paediatric and adult cancers ( Dr David Hyman - Memorial Sloan Kettering Cancer Centre, New York, USA )
3 Jun 2017
Routine genomic testing is feasible, but only a subset of patients benefit
Dr Olivier Trédan - Centre Léon Bérard, Lyon, France
Routine genomic testing is feasible, but only a subset of patients benefit ( Dr Olivier Trédan - Centre Léon Bérard, Lyon, France )
3 Jun 2017
Molecular profiles and the future of adjuvant therapy
Dr Rodrigo Dienstmann - Vall d’Hebron Institute of Oncology, Barcelona, Spain
Molecular profiles and the future of adjuvant therapy ( Dr Rodrigo Dienstmann - Vall d’Hebron Institute of Oncology, Barcelona, Spain )
3 Jun 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation